You are here

  • Home
  • Archive
  • Volume 28, Issue 4
  • A Randomized Phase 2 Study of ADXS11-001 Listeria monocytogenes–Listeriolysin O Immunotherapy With or Without Cisplatin in Treatment of Advanced Cervical Cancer

Article info

Article menu
Download PDFPDF
Cervical Cancer
A Randomized Phase 2 Study of ADXS11-001 Listeria monocytogenes–Listeriolysin O Immunotherapy With or Without Cisplatin in Treatment of Advanced Cervical Cancer

Authors

  1. Address correspondence and reprint requests to Partha Basu, MD, DNB, Screening Group, Early Detection and Prevention Section, International Agency for Research on Cancer (WHO), 150 Cours Albert Thomas, 69372 Lyon Cedex 08, France. E-mail: BasuP{at}iarc.fr.

Citation

Basu P, Mehta A, Jain M, et al
A Randomized Phase 2 Study of ADXS11-001 Listeria monocytogenes–Listeriolysin O Immunotherapy With or Without Cisplatin in Treatment of Advanced Cervical Cancer
International Journal of Gynecologic Cancer 2018;28:764-772.

Publication history

  • Received October 11, 2017
  • Accepted February 7, 2018
  • First published May 1, 2018.
Online issue publication 
January 27, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2018 by the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology.